Using Nomograms to Predict Patient Tolerance to High‐Dose Cisplatin During Concurrent Chemoradiotherapy in Locoregionally Advanced Head and Neck Cancer

Ähnliche Einträge

• Clinical outcomes of cetuximab‐based treatment for distant metastatic head and neck squamous cell carcinoma: A real‐world study using Taiwan Head Neck Society registry database
  von: Hsueh‐Ju Lu, et al.
  Veröffentlicht: (2024)
• Response to Letter to the Editor: Fully COVID ‐19 Vaccinated Status Enhanced the Efficacy of Immune Checkpoint Inhibitors in Patients With Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma
  von: Chien‐Chung Wang, et al.
  Veröffentlicht: (2026)
• Efficacy and Failure Patterns Following Target Volume and Dose Reduction After Neoadjuvant Therapy in Locoregionally Advanced Head and Neck Squamous Cell Carcinoma
  von: Xiong Zhou, et al.
  Veröffentlicht: (2024)
• L‐Carnitine to Reduce Chemoradiotherapy‐Induced Toxicity in Head and Neck Cancer: A Randomized Study
  von: Kumari Puja, et al.
  Veröffentlicht: (2025)
• Outcome Analysis of Solitary Extramedullary Plasmacytoma in the Head and Neck: A Clinical Perspective
  von: Po‐Wen Chuang, et al.
  Veröffentlicht: (2024)